172 related articles for article (PubMed ID: 34862568)
1. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
[TBL] [Abstract][Full Text] [Related]
2. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
3. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
[TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
6. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
7. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
Yuan H; Bao X; Du YZ; You J; Hu FQ
Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterisation and enhanced apoptotic effect of gemcitabine-loaded albumin nanoparticles coating with chitosan.
Salim EI; Abd El Khalik EAM; Shalaby TI; Ali EMM
Arch Physiol Biochem; 2022 Aug; 128(4):970-978. PubMed ID: 32212969
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery.
Bhattacharya S; Anjum MM; Patel KK
Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113
[TBL] [Abstract][Full Text] [Related]
12. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.
Ramasamy T; Tran TH; Cho HJ; Kim JH; Kim YI; Jeon JY; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 May; 31(5):1302-14. PubMed ID: 24297070
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment.
Verma R; Singh V; Koch B; Kumar M
Colloids Surf B Biointerfaces; 2023 Jun; 226():113308. PubMed ID: 37088058
[TBL] [Abstract][Full Text] [Related]
15. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system.
Xie YT; Du YZ; Yuan H; Hu FQ
Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
18. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells.
Fahmy SA; Ramzy A; Mandour AA; Nasr S; Abdelnaser A; Bakowsky U; Azzazy HME
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214139
[TBL] [Abstract][Full Text] [Related]
19. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
20. Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma cell lines.
Abadi B; Khazaeli P; Forootanfar H; Ranjbar M; Ahmadi-Zeidabadi M; Nokhodchi A; Ameri A; Adeli-Sardou M; Amirinejad M
Int J Pharm; 2023 Apr; 637():122884. PubMed ID: 36966981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
